Cite
MLA Citation
Pablo Fernandez-Penas et al.. “799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A477–A478. http://access.bl.uk/ark:/81055/vdc_100144731873.0x000005